Skip to content
healthcare.dev

Liothyronine sodium

NDC 70377-116, Liothyronine sodium, tablet, from Biocon Pharma Inc..

Product NDC
70377-116
Status
Listed
Labeler
Biocon Pharma Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218070
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70377-116 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM50 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
70377-116-117037701161190 TABLET in 1 BOTTLE (70377-116-11)
70377-116-1270377011612100 TABLET in 1 BOTTLE (70377-116-12)
70377-116-13703770116131000 TABLET in 1 BOTTLE (70377-116-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/21002702-422b-1402-73b8-670314d8e579
  • NADAC price for package 70377011612

    GET /v1/drugs/nadac/70377011612

Use it

Look up 70377-116 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70377-116 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70377-116. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.